U.S. PMTA: vape new product rejections keep coming

The war against new vape products continues in the U.S. On May 12, the U.S. Food and Drug Administration (FDA) notified 10 new companies of the denial of their new marketing applications (PMTAs). In keeping with the organization’s current practice, the FDA argued that the evidence provided by the companies did not demonstrate that their products were “suitable for the protection of public health,” and therefore the FDA denied their PMTAs altogether. the denials thus prevented the sale of the 6,500 products that were the subject of the requests on U.S. soil. “Today’s decision to reject approximately 6,500 products is based on insufficient scientific evidence provided in the petition,” said Dr. Matthew Farrelly, director of the FDA’s Center for Tobacco Products (CTP) Office of Science.

Yesterday, May 18, the FDA announced that new products have been denied for marketing in the United States. The denials involve more than 250 e-liquids under the Mothers Milk WTA brand.

As a reminder, since 2020, the FDA has received more than 26 million marketing applications for vape products. At the time of writing these lines, the number of products accepted. The purpose of the ……20 Oversight and Accountability Committee is to “provide transparency and ensure that the CTP is performing its functions.

But while awaiting the outcome, the FDA continues to be responsible for the regulation of tobacco products in the country and therefore retains full authority over e-cigarette products.